New 7‐hydroxycoumarin acetamide derivatives as human carbonic anhydrase IX and XII inhibitors: Design, synthesis, biological evaluation and molecular docking studies
Archiv der Pharmazie · 2025
DOI: 10.1002/ardp.202400482 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Sarvan Maddipatla und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Sciences, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana, India. Hauptthemen laut MEDLINE: Carbonic Anhydrase Inhibitors, Carbonic Anhydrase IX, Coumarins, Molecular Docking Simulation. Die Arbeit nennt 48 Literaturangaben. Gefördert von: None.
Abstract (Originalsprache)
Carbonic anhydrases (CAs) are crucial in regulating various physiological processes in the body. The overexpression of isoforms human carbonic anhydrases (hCA) IX and hCA XII is linked to tumour progression. The selective inhibition of CA IX and CA XII isoforms can result in the development of better cancer treatment strategies. The tail approach based on coumarin derivatives was known for selective inhibition of isoforms IX and XII. This study explores the potential of coumarin derivatives ( 7a–k , 8a–s and 9a–g ) as selective hCA IX and hCA XII inhibitors. The synthesised derivatives exhibited potent and selective inhibition towards hCA IX and XII, with K i values in the range of 0.58‒3.33 µM and 0.48‒2.59 µM, respectively. The oxime ether derivative 7d was found to be the most potent one against hCA IX, with a K i value of 0.58 µM, and phenyl hydrazine derivative 8a , with a K i value of 0.48 µM against hCA XII, was the most potent one among the synthesised molecules. The potent isoform‐specific carbonic anhydrase IX and XII inhibition suggests that 7d and 8a can be taken further towards the development of potent anticancer agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Sciences, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana, India.
- Department of NEUROFARBA, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Polo Scientifico, Sesto Fiorentino, Firenze, Italy.
- Department of Biological Sciences, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana, India.
- Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana, India.
Förderung
- None
Zitieren
APA
Maddipatla, S., Bakchi, B., Shinde, M. A., Bonardi, A., Raman, P. K., Bhalerao, H. A., Singampalli, A., Nanduri, S., Godugu, C., Sonti, R., Supuran, C. T., & Yaddanapudi, V. M. (2025). New 7‐hydroxycoumarin acetamide derivatives as human carbonic anhydrase IX and XII inhibitors: Design, synthesis, biological evaluation and molecular docking studies. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400482
Vancouver
Maddipatla S, Bakchi B, Shinde MA, Bonardi A, Raman PK, Bhalerao HA, et al. New 7‐hydroxycoumarin acetamide derivatives as human carbonic anhydrase IX and XII inhibitors: Design, synthesis, biological evaluation and molecular docking studies. Archiv der Pharmazie. 2025. doi:10.1002/ardp.202400482
BibTeX
@article{Maddipatla2025,
author = {Maddipatla, Sarvan and Bakchi, Bulti and Shinde, Mayura Anil and Bonardi, Alessandro and Raman, Preethi K and Bhalerao, Harshada Anil and Singampalli, Anuradha and Nanduri, Srinivas and Godugu, Chandraiah and Sonti, Rajesh and Supuran, Claudiu T and Yaddanapudi, Venkata Madhavi},
title = {New 7‐hydroxycoumarin acetamide derivatives as human carbonic anhydrase IX and XII inhibitors: Design, synthesis, biological evaluation and molecular docking studies},
journal = {Archiv der Pharmazie},
year = {2025},
doi = {10.1002/ardp.202400482}
}
EUVIMED